Cristina Sampaio Selected Research

Analgesics (Analgesic Drugs)

11/2020	Interpretation of chronic pain clinical trial outcomes: IMMPACT recommended considerations.
11/2013	Abuse liability measures for use in analgesic clinical trials in patients with pain: IMMPACT recommendations.
5/2010	Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations.
1/2006	[Botulinum toxin for the treatment of pain syndromes].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cristina Sampaio Research Topics

Disease

19	Huntington Disease (Huntington's Disease) 08/2023 - 07/2009
19	Parkinson Disease (Parkinson's Disease) 01/2017 - 01/2005
7	Disease Progression 01/2022 - 05/2005
7	Dyskinesias (Dyskinesia) 01/2019 - 05/2005
5	Torticollis (Wryneck) 01/2021 - 01/2016
5	Pain (Aches) 11/2020 - 01/2006
5	Alzheimer Disease (Alzheimer's Disease) 07/2014 - 01/2007
3	Orthostatic Hypotension (Postural Hypotension) 09/2023 - 10/2011
3	Chorea (Rheumatic Chorea) 01/2022 - 07/2009
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 07/2009
3	Melanoma (Melanoma, Malignant) 01/2021 - 01/2010
3	Restless Legs Syndrome (Restless Legs) 01/2019 - 01/2018
3	Sleepiness 01/2016 - 04/2010
3	Dizziness (Lightheadedness) 02/2015 - 04/2010
3	Dementia (Dementias) 07/2013 - 06/2007
2	Dystonia (Limb Dystonia) 01/2022 - 01/2006
2	Neoplasms (Cancer) 01/2019 - 12/2017
2	Seizures (Absence Seizure) 01/2017 - 06/2013
2	Disorders of Excessive Somnolence (Hypersomnia) 01/2016 - 10/2011
2	Meningitis 04/2015 - 08/2011
2	Basilar Skull Fracture (Battle's Sign) 04/2015 - 08/2011
2	Bacterial Meningitis 04/2015 - 08/2011
2	Cognitive Dysfunction 07/2014 - 10/2008
2	Tremor (Tremors) 11/2013 - 09/2010
2	Chronic Pain 07/2013 - 05/2010
2	Respiratory Insufficiency (Respiratory Failure) 12/2012 - 12/2008
2	Fatigue 10/2011 - 05/2010
2	Nausea 07/2011 - 04/2010
2	Headache (Headaches) 04/2010 - 04/2008
2	Parkinsonian Disorders (Parkinsonism) 07/2009 - 05/2005
1	Atrophy 01/2023
1	Inflammation (Inflammations) 01/2022
1	Movement Disorders (Movement Disorder) 01/2022
1	Substance-Related Disorders (Drug Abuse) 01/2021
1	Marijuana Use 01/2021
1	Hemifacial Spasm 11/2020
1	Blepharospasm 11/2020
1	Non-Muscle Invasive Bladder Neoplasms 01/2019
1	Thyroid Neoplasms (Thyroid Cancer) 12/2017
1	Chronic Subdural Hematoma 01/2017

Drug/Important Bio-Agent (IBA)

14	Biomarkers (Surrogate Marker)IBA 08/2023 - 01/2007
11	Levodopa (L Dopa)FDA LinkGeneric 09/2023 - 05/2005
7	Type A Botulinum Toxins (Botox)FDA Link 01/2021 - 10/2011
4	Tetrabenazine (Nitoman)FDA Link 01/2022 - 07/2009
4	Analgesics (Analgesic Drugs)IBA 11/2020 - 01/2006
4	Dopamine Agonists (Dopamine Agonist)IBA 01/2019 - 03/2006
4	Pramipexole (Mirapex)FDA LinkGeneric 01/2018 - 07/2011
4	Anticonvulsants (Antiepileptic Drugs)IBA 01/2017 - 12/2008
4	rasagiline (Azilect)FDA Link 02/2015 - 05/2005
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2005
3	Clozapine (Clozaril)FDA LinkGeneric 01/2018 - 10/2011
3	Proteins (Proteins, Gene)FDA Link 12/2017 - 11/2009
3	Anti-Bacterial Agents (Antibiotics)IBA 04/2015 - 01/2008
3	Pergolide (Permax)FDA Link 10/2011 - 03/2006
3	entacapone (Comtan)FDA Link 12/2010 - 01/2008
2	Huntingtin ProteinIBA 01/2022 - 09/2014
2	Antidepressive Agents (Antidepressants)IBA 01/2021 - 10/2011
2	EnzymesIBA 01/2020 - 01/2017
2	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2020 - 01/2017
2	Amantadine (Aman)FDA LinkGeneric 01/2018 - 10/2011
2	Botulinum Toxins (Botulinum Toxin)IBA 10/2016 - 01/2006
2	rimabotulinumtoxinB FDA Link 10/2016 - 01/2016
2	Pain-FreeIBA 07/2013 - 04/2008
2	Opioid Analgesics (Opioids)IBA 12/2012 - 12/2008
2	Carbidopa (Lodosyn)FDA LinkGeneric 10/2011 - 12/2010
2	pardoprunoxIBA 07/2011 - 04/2010
2	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 12/2010 - 01/2008
2	nebicaponeIBA 12/2010 - 01/2008
2	Phosphotransferases (Kinase)IBA 06/2007 - 03/2006
2	Leucine (L-Leucine)FDA Link 06/2007 - 03/2006
1	deutetrabenazineIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	VemurafenibIBA 01/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021
1	Cholinergic Antagonists (Anticholinergics)IBA 01/2021
1	Trihexyphenidyl (Artane)FDA LinkGeneric 01/2021
1	Everolimus FDA Link 01/2021
1	Anesthetics (Anesthetic Agents)IBA 11/2020
1	Dopamine Receptors (Dopamine Receptor)IBA 01/2020
1	Formaldehyde (Formol)FDA Link 01/2019
1	Antipsychotic Agents (Antipsychotics)IBA 01/2019
1	rotigotine FDA Link 01/2019
1	ParaffinIBA 01/2019
1	Pregabalin (Lyrica)FDA Link 01/2018
1	ferric carboxymaltoseIBA 01/2018
1	Dopamine Agents (Dopaminergic Agents)IBA 01/2018
1	LigandsIBA 01/2018
1	abobotulinumtoxinA FDA Link 12/2017
1	incobotulinumtoxinA FDA Link 12/2017
1	somatotropin releasing hormone receptorIBA 12/2017
1	Har(29)- Arg(28) Nle(27) Orn(21) His(20) Orn(12,) Abu(15) His(11) Tyr(Me)(10) Har(9) Ala(8) Fpa(5,6) Arg(2) (PhAc-Ada)(0)-Tyr(1) GHRH(1-29)NH2IBA 12/2017
1	Growth Hormone-Releasing Hormone (Somatotropin Releasing Hormone)IBA 12/2017
1	Messenger RNA (mRNA)IBA 12/2017
1	neuromelaninIBA 01/2017

Therapy/Procedure

19	Therapeutics 01/2022 - 04/2008
4	Activities of Daily Living (ADL) 11/2013 - 03/2008
3	Antibiotic Prophylaxis 04/2015 - 01/2008
2	Secondary Prevention 07/2013 - 05/2008
1	Kidney Transplantation 01/2019
1	Precision Medicine 05/2018